Skip to main content

Table 2 The ten most commonly prescribed drugs in 2009 for multimorbid patients (n = 164,513) aged 65–94 years, by sex and age groups, attended at primary healthcare centres located in Barcelona

From: Medication patterns in older adults with multimorbidity: a cluster analysis of primary care patients

 

Women

Men

ATC codea

Drug name

N

%

ATC codea

Drug name

N

%

65–79 years

A02BC

Proton pump inhibitors

32,634

41.8

C10AA

HMG CoA reductase inhibitors

18,188

43.4

C10AA

HMG CoA reductase inhibitors

32,004

41.0

A02BC

Proton pump inhibitors

15,170

36.2

N05BA

Benzodiazepine derivatives

20,649

26.5

B01AC

Platelet aggregation inhibitors excl. Heparin

13,872

33.1

N02BE

Anilides

18,434

23.6

C09AA

ACE inhibitors, plain

9748

23.2

B01AC

Platelet aggregation inhibitors excl. Heparin

15,338

19.7

G04CA

Alpha-adrenoreceptor antagonists

7235

17.3

C09AA

ACE inhibitors, plain

13,578

17.4

A10BA

Biguanides

6306

15.0

M05BA

Bisphosphonates

13,309

17.1

N05BA

Benzodiazepine derivatives

6019

14.4

N06AB

Selective serotonin reuptake inhibitors

11,522

14.8

C08CA

Dihydropyridine derivatives

5996

14.3

C03AA

Thiazides, plain

10,112

13.0

C07AB

Beta blocking agents, selective

5934

14.2

C09CA

Angiotensin II antagonists, plain

9231

11.8

N02BE

Anilides

5625

13.4

80–94 years

A02BC

Proton pump inhibitors

16,496

51.8

A02BC

Proton pump inhibitors

5877

46.2

N02BE

Anilides

11,370

35.7

B01AC

Platelet aggregation inhibitors excl. Heparin

5641

44.3

C10AA

HMG CoA reductase inhibitors

11,222

35.2

C10AA

HMG CoA reductase inhibitors

4657

36.6

B01AC

Platelet aggregation inhibitors excl. Heparin

10,512

33.0

C09AA

ACE inhibitors, plain

3235

25.4

N05BA

Benzodiazepine derivatives

9633

30.2

N02BE

Anilides

2638

20.7

C09AA

ACE inhibitors, plain

7223

22.7

G04CA

Alpha-adrenoreceptor antagonists

2601

20.4

C08CA

Dihydropyridine derivatives

5283

16.6

N05BA

Benzodiazepine derivatives

2313

18.2

C03CA

Sulfonamides, plain

5265

16.5

C08CA

Dihydropyridine derivatives

2260

17.8

N06AB

Selective serotonin reuptake inhibitors

5258

16.5

C03CA

Sulfonamides, plain

1930

15.2

C09CA

Angiotensin II antagonists, plain

4502

14.1

C01DA

Organic nitrates

1622

12.7

  1. Codea: chemical subgroup, 4rt level, ATC code (Anatomical Therapeutic Chemical classification) from the World Health Organization (Additional file 1)
  2. For more details, visit webside: https://www.whocc.no/atc/structure_and_principles/